Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole for Esophageal Mucin Production in GERD
NCT00222170Phase 2Completed
- Sponsor
- University of Kansas
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rabeprazole in gastroesophageal reflux disease (GERD), sponsored by University of Kansas. Started May 2005; status: completed.
02
Drugs
rabeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00222170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00222170.